Scientific paper - Original scientific paper
Promoter Methylation Status of ASC/TMS1/PYCARD is Associated with Decreased Overall Survival and TNM Status in Patients with Early Stage Non-small Cell Lung Cancer (NSCLC).
Translational Lung Cancer Research, 8 (2019), 6; 1000-1015. https://doi.org/10.21037/tlcr.2019.12.08


Institutional repository: Repository UHC Osijek

Cite this document

Šutić, M., Motzek, A., Bubanović, G., Linke, M., Sabol, I., Vugrek, O. ... Knežević, J. (2019). Promoter Methylation Status of ASC/TMS1/PYCARD is Associated with Decreased Overall Survival and TNM Status in Patients with Early Stage Non-small Cell Lung Cancer (NSCLC).. Translational Lung Cancer Research, 8. (6), 1000-1015. doi: 10.21037/tlcr.2019.12.08

Šutić, Maja, et al. "Promoter Methylation Status of ASC/TMS1/PYCARD is Associated with Decreased Overall Survival and TNM Status in Patients with Early Stage Non-small Cell Lung Cancer (NSCLC).." Translational Lung Cancer Research, vol. 8, no. 6, 2019, pp. 1000-1015. https://doi.org/10.21037/tlcr.2019.12.08

Šutić, Maja, Antje Motzek, Gordana Bubanović, Matthias Linke, Ivan Sabol, Oliver Vugrek, Petar Ozretić, et al. "Promoter Methylation Status of ASC/TMS1/PYCARD is Associated with Decreased Overall Survival and TNM Status in Patients with Early Stage Non-small Cell Lung Cancer (NSCLC).." Translational Lung Cancer Research 8, no. 6 (2019): 1000-1015. https://doi.org/10.21037/tlcr.2019.12.08

Šutić, M., et al. (2019) 'Promoter Methylation Status of ASC/TMS1/PYCARD is Associated with Decreased Overall Survival and TNM Status in Patients with Early Stage Non-small Cell Lung Cancer (NSCLC).', Translational Lung Cancer Research, 8(6), pp. 1000-1015. doi: 10.21037/tlcr.2019.12.08

Šutić M, Motzek A, Bubanović G, Linke M, Sabol I, Vugrek O, and sur.. Promoter Methylation Status of ASC/TMS1/PYCARD is Associated with Decreased Overall Survival and TNM Status in Patients with Early Stage Non-small Cell Lung Cancer (NSCLC).. Translational Lung Cancer Research [Internet]. 2019 [cited 2024 March 29];8(6):1000-1015. doi: 10.21037/tlcr.2019.12.08

M. Šutić, et al., "Promoter Methylation Status of ASC/TMS1/PYCARD is Associated with Decreased Overall Survival and TNM Status in Patients with Early Stage Non-small Cell Lung Cancer (NSCLC).", Translational Lung Cancer Research, vol. 8, no. 6, pp. 1000-1015, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:239:910974. [Accessed: 29 March 2024]